| These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988 | GLENMARK PHARMACEUTICALS INC., USA | Gland Pharma Limited | 20260130 | 2 |
| These highlights do not include all the information needed to use OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION. OCTREOTIDE ACETATE for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 1988 | Mylan Institutional LLC | 20260121 | 1 |
| These highlights do not include all the information needed to use SANDOSTATIN LAR DEPOT safely and effectively. See full prescribing information for SANDOSTATIN LAR DEPOT. SANDOSTATIN ® LAR DEPOT (octreotide acetate) for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 1988 | Novartis Pharmaceuticals Corporation | 20251222 | 29 |
| These highlights do not include all the information needed to use SANDOSTATIN INJECTION safely and effectively. See full prescribing information for SANDOSTATIN INJECTION. SANDOSTATIN ® (octreotide acetate) INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 1988 | Novartis Pharmaceuticals Corporation | 20250811 | 22 |
| These highlights do not include all the information needed to use MYCAPSSA ® safely and effectively. See full prescribing information for MYCAPSSA. MYCAPSSA (octreotide) delayed-release capsules, for oral use Initial U.S. Approval: 1988 | Chiesi USA, Inc. | Almac Pharma Services Limited | Assia Chemical Industries Ltd. - Teva Tech Site | Lyophilization Services of New England, Inc. (LSNE) | MW ENCAP LIMITED | Novetide Ltd. | 20250724 | 6 |
| These highlights do not include all the information needed to use MYCAPSSA ® safely and effectively. See full prescribing information for MYCAPSSA. MYCAPSSA (octreotide) delayed-release capsules, for oral use Initial U.S. Approval: 1988 | Amryt Pharmaceuticals Designated Activity Company | Almac Pharma Services Limited | Assia Chemical Industries Ltd - Teva Tech Site | Lyophilization Services of New England, Inc. (LSNE) | MW ENCAP LIMITED | Novetide Ltd. | 20250724 | 7 |
| These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988 | Sagent Pharmaceuticals | 20250701 | 10 |
| These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 1988 | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | 20250625 | 3 |
| These highlights do not include all the information needed to use BYNFEZIA PEN safely and effectively. See full prescribing information for BYNFEZIA PEN. BYNFEZIA PEN ® (octreotide acetate) injection, for subcutaneous use Initial U.S. Approval: 1988 | Sun Pharmaceutical Industries, Inc. | OneSource Specialty Pharma Limited | 20250221 | 5 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988 | Meitheal Pharmaceuticals, Inc. | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd | 20250116 | 1 |
| These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 1988 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | USV Private Limited | 20241203 | 10 |
| These highlights do not include all the information needed to use OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION . OCTREOTIDE ACETATE for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 1988 | Teva Pharmaceuticals, Inc. | 20240730 | 5 |
| These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988 | Gland Pharma Limited | 20240729 | 7 |
| These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988 | Gland Pharma Limited | 20240725 | 7 |
| These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION . OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988 | Mylan Institutional LLC | 20240715 | 20 |
| These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 1988 | Fresenius Kabi USA, LLC | 20240523 | 6 |
| These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 1988 | Fresenius Kabi USA, LLC | 20240507 | 9 |
| These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988 | Hikma Pharmaceuticals USA Inc. | 20240301 | 11 |
| Octreotide Acetate Injection Rx only | Bryant Ranch Prepack | 20220427 | 101 |
| Rx ONLY | USV North America Inc. | USV Private Limited | 20190107 | 4 |
| Rx Only Prescribing Information | USV North America Inc. | USV Private Limited | 20180921 | 7 |
| Octreotide Acetate Injection | Wockhardt USA LLC. | Wockhardt Limited | 20121010 | 1 |
| Octreotide Acetate Injection | Wockhardt Limited | 20121010 | 1 |